Cardiff Oncology Inc Share Price

NASDAQ: CRDF

Small Cap

$2.00

(+0.25%)

as on September 18, 2025 at 1:29 am IST

$₹

Cardiff Oncology Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's High
$2
Day's Price Range
$2.1
$2
5.00%
Upside
52 Week's Low
52 Week's High
$1.9
52-Week Price Range
$5.64
$2
5.00%
Downside
181.97%
Upside

Cardiff Oncology Inc share price movements today

Previous Close: $2.00
Open: $2.01
Volume: 621.1K
Day's Low - High: $2 - $2.1
52 Week Low - High: $1.9 - $5.64

Cardiff Oncology Inc Historical Returns

1 Month Return: -18.03 %
3 Month Return: -45.95 %
1 Year Return: -21.26 %
3 Year Return: + 26.58 %
5 Year Return: -75.34 %

Cardiff Oncology Inc Stock Fundamentals & Key Indicators

Check Cardiff Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$133.1M

EPS (TTM)

-0.8483

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-53.9M

Revenue (TTM)

545.0K

Profit Margin

0.00%

Return On Equity TTM

29322000.00%

Cardiff Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiff Oncology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cardiff Oncology Inc	BUY	$133.1M	-75.34%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Cardiff Oncology Inc Stock including INR - Dollar returns

The Cardiff Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cardiff Oncology Inc investment value today

Current value as on today

₹83,338

Returns

₹16,662

(-16.66%)

Returns from Cardiff Oncology Inc Stock

₹21,260 (-21.26%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Cardiff Oncology Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cardiff Oncology Inc. Average target price of $10.07

Cardiff Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Cardiff Oncology Inc.

What analysts predicted

80.14%UPSIDE

Target Price

$10.07

Current Price

Analyzed by

10 Analysts

Target

$10.07

Cardiff Oncology Inc target price $10.07, a slight upside of 80.14% compared to current price of $2. According to 10 analysts rating.

Cardiff Oncology Inc Stock's Interest Amongst Investors

Search interest for Cardiff Oncology Inc Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-22% versus previous 30 day period

Cardiff Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-12	-12	-10	-10	-10	-12	-12	-12	-14	-14
EBITDA	-11	-12	-10	-10	-10	-12	-12	-12	-14	-14
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-11	-9	-9	-10	-11	-11	-11	-13	-13
Income Tax Expense	0	-1	-1	2	0	-	-	-	-	-
Net Income	-10	-11	-9	-9	-10	-11	-11	-11	-13	-13
Net Profit Margin	-12522.89%	-10324.07%	-6901.42%	-5985.26%	-4883.41%	-7225.77%	-7184.85%	-7805.96%	-12324.77%	-11528.10%

Cardiff Oncology Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	-1	-1	0	-10	-10	0	0	0	0
Operating Income	-25	-40	-25	-17	-16	-19	-28	-39	-45	-48
EBITDA	-24	-36	-22	-15	-15	-18	-28	-39	-45	-48
Interest Expense	1	1	1	0	0	0	0	1	-	-
Depreciation	-	-	1	0	0	0	0	0	0	0
Income Before Tax	-27	-39	-24	-16	-16	-19	-28	-38	-41	-45
Income Tax Expense	1	0	0	0	0	0	0	-1	0	0
Net Income	-27	-39	-24	-16	-16	-19	-28	-38	-41	-45
Net Profit Margin	-8776.68%	-10289.76%	-4932.08%	-4354.76%	-6699.59%	-5267.85%	-7880.50%	-10026.94%	-8492.01%	-6651.68%

Cardiff Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-9	-9	-10	-11	-11	-11	-13	-13
Operating Cash Flow	-7	-7	-7	-7	-9	-10	-10	-12	-8
Investing Cash Flow	11	3	13	4	14	-9	4	-14	-4
Financing Cash Flow	0	0	0	0	2	7	44	0	-
Change in Cash	4	-4	6	-2	6	-12	38	-27	-13

Cardiff Oncology Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-39	-24	-16	-16	-19	-28	-38	-41	-45
Operating Cash Flow	-31	-23	-13	-13	-16	-23	-33	-30	-37
Investing Cash Flow	-24	23	0	0	0	-131	38	36	13
Financing Cash Flow	2	-6	16	12	137	35	0	-	53
Change in Cash	-53	-5	3	-1	120	-119	4	5	29

Global Institutional Holdings in Cardiff Oncology Inc

Funds	Holdings
COMMODORE CAPITAL LP	8.09%
BlackRock Inc	5.78%
Vanguard Group Inc	4.68%
Blair William & Co	3.79%
Pfizer Inc	3.62%

See all

Insights on Cardiff Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 109.0K → 121.0K (in $), with an average increase of 9.9% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 89.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 89.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -11.78M → -13.94M (in $), with an average decrease of 8.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CRDF stock has moved down by -18.0%

About Cardiff Oncology Inc

trovagene is a precision medicine biotechnology company developing oncology therapeutics for improved cancer care by leveraging its proprietary precision cancer monitoring® (pcm) technology in tumor genomics. trovagene has broad intellectual property and proprietary technology to measure circulating tumor dna (ctdna) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. trovagene offers its pcm technology at its clia/cap – accredited laboratory and plans to continue to vertically integrate its pcm technology with precision cancer therapeutics. trovagene's lead therapeutic asset is pcm-075, an oral, investigational drug and a highly-selective polo-like kinase 1 (plk1) inhibitor for the treatment of acute myeloid leukemia (aml). among the four members of the plk family, plk1 is recognized to be the fundamental component for cell division to take place correctly. most importantly, plk1 is only expressed in dividing cells, wh

Organisation	Cardiff Oncology Inc
Headquarters	11055 Flintkote Avenue, San Diego, CA, United States, 92121
Industry	Health Services
CEO	Dr. Mark Erlander Ph.D.
E-voting on shares	Click here to vote

Key Management of Cardiff Oncology Inc

Name	Title
Dr. Mark Erlander Ph.D.	CEO & Director
Mr. James E. Levine	Chief Financial Officer
Dr. Tod Smeal Ph.D.	Chief Scientific Officer
Ms. Elizabeth Anderson	VP of Finance & Administration
Ms. Brigitte Lindsay	Senior Vice President of Finance
Mr. Charles Monahan R.Ph.	Senior Vice President of Regulatory Affairs
Dr. Roger Sidhu M.D.	Chief Medical Officer

FAQs

What is Cardiff Oncology Inc share price today?

Cardiff Oncology Inc share price today is $2 as on September 18, 2025 at 1:29 am IST at the close of the market. Cardiff Oncology Inc share today touched a day high of $2.1 and a low of $2.

What is the 52 week high and 52 week low for Cardiff Oncology Inc share?

Cardiff Oncology Inc share touched a 52 week high of $5.64 on December 17, 2024 and a 52 week low of $1.9 on September 3, 2025. Cardiff Oncology Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $2,which is 64.54% down from its 52 week high and 5.26% up from its 52 week low.

What is Cardiff Oncology Inc's market capitalisation today?

Cardiff Oncology Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Cardiff Oncology Inc Stock (CRDF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cardiff Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiff Oncology Inc Shares that will get you 0.7500 shares as per Cardiff Oncology Inc share price of $2 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cardiff Oncology Inc Stock (CRDF) from India?

Indian investors can start investing in Cardiff Oncology Inc (CRDF) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 3:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Cardiff Oncology Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 3:44 am IST). Based on Cardiff Oncology Inc share’s latest price of $2 as on September 18, 2025 at 1:29 am IST, you will get 5.0000 shares of Cardiff Oncology Inc. Learn more about fractional shares .

What are the returns that Cardiff Oncology Inc has given to Indian investors in the last 5 years?

Cardiff Oncology Inc stock has given -75.34% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?